0001932525-24-000001.txt : 20240517
0001932525-24-000001.hdr.sgml : 20240517
20240517160458
ACCESSION NUMBER: 0001932525-24-000001
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 24959522
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Davis Andrew
CENTRAL INDEX KEY: 0001932525
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET
STREET 2: SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
144
1
primary_doc.xml
144
0001932525
XXXXXXXX
LIVE
0001446847
IRONWOOD PHARMACEUTICALS INC
001-34620
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
617-621-7722
Davis Andrew
Officer
Class A Common Stock
E Trade Securities LLC
3 Edison Drive
Alpharetta
GA
30005
25105
166697.20
158957123
05/20/2024
Nasdaq
Class A Common Stock
06/01/2021
Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
Ironwood Pharmaceuticals, Inc.
N
20000
06/01/2021
N/A
Class A Common Stock
03/08/2023
Performance-based Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
Ironwood Pharmaceuticals, Inc.
N
37120
03/08/2023
N/A
Y
Shares sold to cover taxes from the vesting of stock awards granted by the Issuer.
05/17/2024
/s/ Andrew Davis